Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/11/25 16:16 | 12/9/25 | MRNA | Health | BioPrd | Biological Products, (No Diag | Hussain Abbas | MA | D | 2 | S | -23 | 27.75 | 0 | -1 | 2 | D | ||||||||||||||||
12/10/24 16:08 | 12/9/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Klinger Shannon Thyme | MA | O | GC | 7 | S.d | -256 | 60.84 | 0 | -4 | 20 | D | |||||||||||||||
12/4/24 17:08 | 12/3/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Hoge Stephen | MA | O | P | 6 | S.d | -108 | 61.61 | 0 | -2 | 0 | 1,600 | D | ||||||||||||||
12/2/24 16:26 | 11/29/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Mock James M | MA | O | CFO | 4 | S.d | -221 | 61.16 | 0 | -4 | 11 | D | |||||||||||||||
8/2/24 19:00 | 7/31/24 | MRNA | Health | BioPrd | Biological Products, (No Diag | Afeyan Noubar | MA | D | 1 | S | -1,799 | 119.96 | 0 | -15 | 0 | 6,856 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |